Sagimet Biosciences Inc. (SGMT) insider trading.
In Q3 2026, insiders at Sagimet Biosciences Inc. reported 9 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $4.5M.
- Transactions
- 9
- Purchases (P)
- 0
- Sales (S)
- 5
- Net shares, P minus S
- -464,633
- Insiders
- 3
- Last filed
- 2026-08-17
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Kemble George | Director | 7 | 0 | 3 |
| Rozek Elizabeth | Officer · Chief Legal & Admin. Officer | 1 | 0 | 1 |
| Happel David | Director, Officer · President & CEO | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-14 | Kemble George | M (A) | 326,618 | $6.36 | 388,779 | Form 4 |
| 2026-08-14 | Kemble George | M (A) | 24,369 | $6.36 | 413,148 | Form 4 |
| 2026-08-14 | Kemble George | S (D) | 350,987 | $10.23 | 62,161 | Form 4 |
| 2026-08-11 | Kemble George | M (A) | 9,751 | $6.36 | 71,912 | Form 4 |
| 2026-08-11 | Kemble George | S (D) | 20,206 | $9.95 | 62,161 | Form 4 |
| 2026-08-11 | Kemble George | M (A) | 10,455 | $6.36 | 82,367 | Form 4 |
| 2026-07-20 | Kemble George | S (D) | 18,844 | $7.46 | 62,161 | Form 4 |
| 2026-07-20 | Rozek Elizabeth | S (D) | 10,545 | $7.76 | 224,414 | Form 4 |
| 2026-07-20 | Happel David | S (D) | 64,051 | $7.76 | 741,570 | Form 4 |
Transaction codes in this quarter
Get SGMT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1400118&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · SGMT company page · Sagimet Biosciences Inc. on SEC.gov
Questions
Are insiders buying or selling Sagimet Biosciences Inc. (SGMT)?
In Q3 2026, insiders at Sagimet Biosciences Inc. reported 9 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $4.5M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Sagimet Biosciences Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/sgmt.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.